Heat Biologics Announces Pricing for Rights Offering

Heat Biologics (NASDAQ:HTBX) shared the $0.62 price for its subscription for a rights offering to the company’s security holders.
As quoted in the press release:

Under the proposed rights offering, Heat will distribute non-transferable subscription rights to purchase shares of common stock to its eligible stockholders and participating warrant holders as of the October 13, 2017 record date. Holders who exercise their subscription rights in full will be entitled to subscribe for additional shares that are not purchased by other shareholders.
The registration statement relating to the rights offering has been filed with the SEC, but has not yet become effective.

Click here to read the full press release.

Source: www.accesswire.com